Literature DB >> 16779768

Cell mimetic monolayer supported chitosan-haemocompatibility studies.

Smitha Mathews1, K Kaladhar, Chandra P Sharma.   

Abstract

Chitosan is a natural polymer, widely explored for biomedical and tissue engineering applications. However the thrombogenic nature limits their application in blood contacting devices and implants. Here, we have attempted to understand the haemocompatibility of chitosan by immobilizing a monolayer of cell mimetic lipid compositions. The phosphatidylcholine/cholesterol/galactocerebroside lipid composition (PC/Chol/GalC, 1:0.35:0.125) was deposited onto the chitosan films. Characterization of the modified surface was done by sessile drop contact angle measurement. The contact angle of the chitosan film reduced from 80.65 +/- 1.4 to 23.5 +/- 1.9 after the surface modification. Swelling nature of chitosan seemed to influence the orientation and packing of the lipid monolayer. In vitro calcification studies with metastable salt solution indicated increased calcification on the modified surface. This may be due to formation of nuclei for calcification on the expanding monolayer. The preliminary haemocompatibility studies with washed platelets, leukocytes and erythrocytes showed overall reduction in blood cell adhesion to the modified surfaces. Scanning electron microscopy was used for morphological characterization of platelet adhesion and activation on the surfaces. On the bare chitosan surface, fully spread platelets with extending pseudopodia indicated platelet activation. The smooth surface of the modified film did not activate platelets. These studies showed that, though the lipid monolayer on chitosan film is able to reduce the over all blood cell adhesion and platelet activation it is prone to calcification. (c) 2006 Wiley Periodicals, Inc

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16779768     DOI: 10.1002/jbm.a.30710

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  4 in total

1.  Small-diameter tissue engineered vascular graft made of electrospun PCL/lecithin blend.

Authors:  Min Zhang; Kai Wang; Zhexiang Wang; Bin Xing; Qiang Zhao; Deling Kong
Journal:  J Mater Sci Mater Med       Date:  2012-07-20       Impact factor: 3.896

2.  Endotoxins affect diverse biological activity of chitosans in matters of hemocompatibility and cytocompatibility.

Authors:  Andrea Nolte; Susanne Hossfeld; Marcell Post; Jan Niederlaender; Tobias Walker; Christian Schlensak; Hans Peter Wendel
Journal:  J Mater Sci Mater Med       Date:  2014-05-31       Impact factor: 3.896

3.  Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release.

Authors:  Gaurav Bajaj; William G Van Alstine; Yoon Yeo
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

4.  Electrospun porous poly(3-hydroxybutyrate-co-4-hydroxybutyrate)/lecithin scaffold for bone tissue engineering.

Authors:  Wei Liu; Tiejun Jiao; Yuran Su; Ran Wei; Zheng Wang; Jiacheng Liu; Na Fu; Lei Sui
Journal:  RSC Adv       Date:  2022-04-19       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.